Biochemistry, Genetics and Molecular Biology
Aneuploidy
6%
Anticancer
9%
Axon
5%
Bone Morphogenetic Protein
7%
Cancer Cell
45%
Cancer Stem Cell
10%
Carcinogenesis
10%
CD8
10%
Cell Death
7%
Cell Fusion
6%
Cell Membrane
7%
Cell Migration
9%
Cell Proliferation
9%
Cyclic Adenosine Monophosphate
16%
DNA Methylation
9%
Downregulation
8%
Drug Resistance
7%
Drug Response
8%
Eicosanoid Receptor
15%
Embryogenesis
8%
Enhancer Region
10%
Enzyme Active Site
6%
Epidermal Growth Factor
7%
Epidermal Growth Factor Receptor
10%
Epigenetics
6%
Estrogen Receptor
7%
Fibroblast
7%
Gene Expression
28%
Genetics
20%
Glycoprotein
7%
Hemojuvelin
17%
Hepatocyte
12%
Hepcidin
28%
Homeostasis
8%
Immune Checkpoints
18%
Immune Response
14%
Immunocompetent Cell
15%
Immunofluorescence
7%
Intestine Innervation
10%
Invadopodia
8%
Involution
10%
Iron Homeostasis
21%
Iron Overload
6%
Iron Poisoning
6%
Iron Transport
6%
Isoform
9%
Kinase
18%
KRAS
7%
Lateral Line
8%
Leukocyte
8%
Macrophage
18%
Manduca
8%
Matriptase
11%
Messenger RNA
33%
MicroRNA
14%
Mitogen-Activated Protein Kinase
11%
Monospecific Antibody
8%
Mouse
35%
Mouse Model
8%
Mutated Genes
5%
N-Terminus
7%
Oligonucleotide
6%
Oncogene
9%
Overall Survival
10%
P53
6%
PD-L1
8%
Phosphotransferase
18%
Poly ADP Ribose Polymerase
6%
Precursor
8%
Prolactin
18%
Promoter Region
18%
Protein Expression
15%
Protein Kinase C
8%
Protein Kinases
13%
Protein Microarray
11%
Proteome
7%
Proteomics
27%
Reprogramming
5%
Response Element
5%
RNA
14%
RNA Sequence
11%
Signal Transduction
23%
Somatic Mutation
7%
Stem Cell
26%
Surface Property
7%
T Cell
27%
Transcription
12%
Transcription Factors
10%
Transcriptome
5%
Transcriptomics
8%
Transferrin
23%
Transferrin Receptor
42%
Transforming Growth Factor
6%
Tumor Progression
24%
Tumor Suppressor Protein
6%
Tumor-Associated Macrophage
7%
Upregulation
7%
Wild Type
15%
Xenopus
6%
Zebra Fish
18%
Medicine and Dentistry
Androgen Receptor
8%
B Cell
6%
Biological Marker
24%
Biopsy
5%
Breast Cancer
68%
Breast Carcinoma
5%
Breast Tumor
5%
Cancer Cell
16%
Cancer Growth
9%
Cancer Immunotherapy
5%
Cancer Model
6%
Cancer Risk
5%
Cancer Stem Cell
8%
Cancer Therapy
10%
Cancer Types
5%
Cellular Infiltration
8%
Childbirth
5%
Colorectal Cancer
6%
Combination Therapy
11%
Cytotoxic T-Cell
15%
Dendritic Cell
5%
Disease
10%
Drug Resistance
7%
Endometrial Cancer
5%
Epithelial Cell
8%
Gene Expression
8%
Head and Neck Squamous Cell Carcinoma
13%
Hybrid Cell
10%
Immune Checkpoint Inhibitor
6%
Immune Response
11%
Immunocompetent Cell
15%
Immunohistochemistry
9%
Immunotherapy
17%
Intraductal Carcinoma
6%
Involution
10%
Leukocyte
7%
Liver Metastasis
5%
Lung Cancer
5%
Lymph Duct
15%
Macrophage
19%
Malignant Neoplasm
72%
Metastatic Carcinoma
23%
microRNA
6%
Myeloid Cell
9%
Neoplasm
100%
Nodular Melanoma
13%
Nulliparous
5%
Oncology
6%
Ovarian Cancer
17%
Overall Survival
8%
Pancreas Adenocarcinoma
10%
Pancreas Cancer
11%
PARP Inhibitor
10%
Primary Tumor
7%
Progression Free Survival
5%
Prostate Cancer
6%
Protein Expression
6%
Protein Microarray
6%
Proteomics
5%
Signal Transduction
7%
Solid Malignant Neoplasm
8%
Stem Cell
5%
Stroma
7%
T Cell
16%
Tamsulosin
6%
Targeted Therapy
12%
The Cancer Genome Atlas
12%
Treatment Response
6%
Triple Negative Breast Cancer
13%
Tumor Cell
18%
Tumor Immune Microenvironment
5%
Tumor Microenvironment
15%
Tumor Progression
19%
Keyphrases
Breast Cancer
9%
Ca2+
7%
Cancer Cells
6%
Cancer Genome Atlas
5%
CD8+ T Cells
8%
Complementary DNA (cDNA)
7%
Confidence Interval
5%
Cytoplasmic Domain
5%
Endothelin-1 (ET-1)
7%
Epidermal Growth Factor
12%
Fibroblasts
7%
Gene Expression
14%
Glycoprotein Hormone
5%
Gonadotropin-releasing Hormone
6%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
6%
Hemojuvelin
10%
Hepatocytes
5%
Hepcidin
8%
Hepcidin Expression
10%
Hereditary Hemochromatosis
11%
Hybrid Cells
7%
Immune Cells
5%
In Cancer
11%
Invadopodia
5%
Iron Homeostasis
12%
Iron Transport
5%
Iron Uptake
5%
Liver
6%
Macrophages
9%
Metastasis
6%
Microenvironment
9%
Mitogen-activated Protein Kinase
7%
Molecular Characterization
6%
MRNA Level
5%
Neogenin
7%
Nucleotide Sequence
5%
Pan-cancer Analysis
9%
Pancreatic Cancer
7%
PARP Inhibitor (PARPi)
6%
Phosphorylation
7%
Pituitary
9%
Pituitary Cells
6%
Postpartum Breast Cancer
6%
Programmed Death-ligand 1 (PD-L1)
5%
Prolactin
11%
Prolactin Gene
11%
Prolactin Promoter
5%
Protein Kinase
12%
Solid Tumors
6%
T Cells
9%
TfR2
14%
Thyrotropin
8%
Transferrin
10%
Transferrin Receptor 1 (TfR1)
18%
Tumor
22%
Tumor Cells
8%
Tumor Microenvironment
16%
Tumor Progression
6%
VL30
6%
Whole Genome
12%
Young Breast Cancer
5%
Zebrafish
6%